First Page | Document Content | |
---|---|---|
![]() Date: 2013-01-31 06:44:37Rare diseases Birt–Hogg–Dubé syndrome Folliculin Signal transduction Macrolides Protein kinases Mammalian target of rapamycin Renal cell carcinoma Vascular endothelial growth factor Biology Health Medicine | Add to Reading List |
![]() | Birt-Hogg-Dubé syndrome: diagnosis and managementDocID: 1ovL7 - View Document |
![]() | PDF DocumentDocID: 1a4Me - View Document |
![]() | Copyright Myrovlytis Trust December, 2014 What is BHD? ContentsDocID: LR1L - View Document |
![]() | Birt-Hogg-Dubé Newsletter December 2014 Vol.13, No.4 You are receiving this email because you have expressed an interest in BHD. We hope you will enjoy this andDocID: LKsC - View Document |
![]() | Charity Officer – Myrovlytis Trust The Myrovlytis Trust is a medical charity promoting research into rare genetic kidney disorders such as Birt-Hogg-Dubé syndrome. Since 2007, we have awarded over £4.5 million in resDocID: Kl8x - View Document |